In the present study, the fact that ARBs increase in plasma sPRR parallel augmentation of PRA support further support the concept that plasma sPRR is an indicator of systemic RAS activation in women with type 2 diabetes. Here, S100A6 is linked to type 2 diabetes mellitus.